Neuraxial analgesia is not associated with an increased risk of post-partum relapses in MS.

Date publication

avril 2019

Journal

Multiple sclerosis (Houndmills, Basingstoke, England)

Auteurs

Membres identifiés du Cancéropôle Est :
Pr DE SEZE Jérôme

Tous les auteurs :
Lavie C, Rollot F, Durand-Dubief F, Marignier R, Ionescu I, Casey R, Moreau T, Tourniaire P, Hutchinson M, D'Hooghe MB, Laplaud DA, Clavelou P, De Sèze J, Debouverie M, Brassat D, Pelletier J, Lebrun-Frenay C, Le Page E, Castelnovo G, Berger E, Hautecoeur P, Heinzlef O, Durelli L, Clerico M, Trojano M, Patti F, Vukusic S,

Lien Pubmed

http://www.ncbi.nlm.nih.gov/pubmed/31081475

Résumé

Obstetrical analgesia remains a matter of controversy because of the fear of neurotoxicity of local anesthetics on demyelinated fibers or their potential relationship with subsequent relapses.

Mots clés

Multiple sclerosis, neuraxial analgesia, post-partum, pregnancy, relapses

Référence

Mult. Scler.. 2019 Apr;25(4):591-600